Regeneron Pharmaceuticals, Inc. (BMV:REGN)

Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,241,261	1,596,963	1,579,070	1,503,072	1,353,626	1,014,611
Market Cap Growth	-42.65%	1.13%	5.06%	11.04%	33.41%	31.05%
Enterprise Value	943,842	1,272,245	1,359,471	1,302,370	1,174,855	950,813
Last Close Price	12200.00	14470.93	14644.72	13777.59	13172.99	9481.10
PE Ratio	14.78	17.37	23.63	17.76	8.18	14.51
PS Ratio	4.75	5.40	7.12	6.33	4.11	6.00
PB Ratio	2.19	2.61	3.60	3.40	3.52	4.63
P/TBV Ratio	2.29	2.72	3.75	3.54	3.52	4.63
P/FCF Ratio	16.03	20.91	24.10	17.42	10.11	25.45
P/OCF Ratio	13.34	17.34	20.33	15.37	9.32	19.48
EV/Sales Ratio	3.57	4.30	6.13	5.49	3.57	5.62
EV/EBITDA Ratio	11.60	13.19	17.28	12.51	6.18	12.25
EV/EBIT Ratio	13.30	14.73	19.00	13.37	6.37	13.04
EV/FCF Ratio	12.19	16.66	20.75	15.09	8.78	23.85
Debt / Equity Ratio	0.09	0.10	0.11	0.12	0.14	0.25
Debt / EBITDA Ratio	0.62	0.63	0.60	0.52	0.29	0.69
Debt / FCF Ratio	0.64	0.80	0.72	0.63	0.41	1.35
Asset Turnover	0.37	0.40	0.42	0.45	0.76	0.53
Inventory Turnover	2.46	2.51	2.51	2.37	2.74	2.26
Quick Ratio	3.19	3.86	4.82	4.16	2.98	2.86
Current Ratio	4.06	4.73	5.69	5.06	3.56	3.63
Return on Equity (ROE)	15.19%	15.95%	16.26%	20.94%	54.21%	31.77%
Return on Assets (ROA)	6.16%	7.31%	8.49%	11.42%	26.39%	14.33%
Return on Capital (ROIC)	7.27%	8.49%	9.76%	13.31%	31.95%	17.95%
Return on Capital Employed (ROCE)	10.70%	12.30%	14.30%	19.20%	41.80%	25.30%
Earnings Yield	6.76%	5.76%	4.23%	5.63%	12.23%	6.89%
FCF Yield	6.24%	4.78%	4.15%	5.74%	9.89%	3.93%
Buyback Yield / Dilution	4.39%	-1.23%	-0.18%	-1.16%	2.52%	-0.44%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.